Related Experiment Video
Updated: Jan 8, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
ATRIAL FIBRILLATION: A REVIEW OF CONTEMPORARY EPIDEMIOLOGY AND ROLE OF INFLAMMATION IN THE PATHOPHYSIOLOGY
A P Duduyemi1, A Aje1, F A Ajao2
1Department of Medicine, University College Hospital, Ibadan.
Inflammation plays a key role in Atrial Fibrillation (AF). Elevated inflammatory markers like C-reactive protein and tumor necrosis factor are linked to AF development and severity, suggesting new treatment targets.
Area of Science:
- Cardiology
- Immunology
- Epidemiology
Background:
- Atrial Fibrillation (AF) is a growing global health concern, contributing significantly to cardiovascular morbidity and mortality.
- Its pathophysiology involves complex cardiac remodeling, but emerging evidence highlights the role of inflammatory markers.
- Understanding these markers is crucial for addressing the rising incidence of AF.
Purpose of the Study:
- To review the current epidemiology of Atrial Fibrillation.
- To investigate the role of specific inflammatory markers in the pathogenesis of AF.
Main Methods:
- A narrative literature review was conducted.
- Contemporary epidemiological data on AF was analyzed.
- The focus was on the association between inflammatory markers (IL-2, IL-6, CRP, TNF) and AF.
Main Results:
- AF prevalence and incidence have significantly increased globally.
- Elevated C-reactive protein (CRP) predicts AF risk.
- Tumor necrosis factor (TNF) and Interleukin-6 (IL-6) are linked to AF pathogenesis, severity, and atrial remodeling.
Conclusions:
- Inflammatory markers are significantly associated with the increased incidence and prevalence of Atrial Fibrillation.
- Targeting inflammation may offer novel strategies for AF prevention and treatment.
- Further research into inflammatory pathways could improve patient outcomes and reduce AF complications.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Myocarditis I: Introduction
Pericarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations